رجوع
مُدرج أيضًا باسم
HLN
NYSE
نطاق اليوم
KWD 4.86
KWD 4.86
نطاق 52 أسبوعًا
KWD 4.25
KWD 5.80
حجم التداول
2,504
متوسط 50 يوم / 200 يوم
KWD 5.22
/
KWD 4.92
الإغلاق السابق
KWD 5.03
Quick Summary
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (633 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 26.7 | 0.2 |
| P/B | 2.7 | 2.8 |
| ROE % | 10.2 | 3.7 |
| Net Margin % | 15.1 | 3.9 |
| Rev Growth 5Y % | 3.7 | 9.7 |
| D/E | 0.5 | 0.2 |
Dividend History
Yield
0.02%
Payout Ratio
N/A
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
النقاط الرئيسية
Revenue grew 3.68% annually over 5 years — modest growth
Earnings grew 15.58% over the past year
ROE of 10.23% — decent returns on equity
Net margin of 15.11% shows strong profitability
Generating 2.01B in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 5.50%
النمو
Revenue Growth (5Y)
3.68%
Revenue (1Y)-1.82%
Earnings (1Y)15.58%
FCF Growth (3Y)6.87%
الجودة
Return on Equity
10.23%
ROIC7.41%
Net Margin15.11%
Op. Margin22.44%
الأمان
Debt / Equity
0.52
Current Ratio0.92
Interest Coverage7.28
التقييم
P/E Ratio
26.72
Forward P/EN/A
P/B Ratio2.71
EV/EBITDA20.94
Dividend Yield0.02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -1.82% | Revenue Growth (3Y) | -1.22% |
| Earnings Growth (1Y) | 15.58% | Earnings Growth (3Y) | 26.05% |
| Revenue Growth (5Y) | 3.68% | Earnings Growth (5Y) | 4.64% |
| Profitability | |||
| Revenue (TTM) | 11.03B | Net Income (TTM) | 1.67B |
| ROE | 10.23% | ROA | 5.11% |
| Gross Margin | 64.77% | Operating Margin | 22.44% |
| Net Margin | 15.11% | Free Cash Flow (TTM) | 2.01B |
| ROIC | 7.41% | FCF Growth (3Y) | 6.87% |
| Safety | |||
| Debt / Equity | 0.52 | Current Ratio | 0.92 |
| Interest Coverage | 7.28 | ||
| Dividends | |||
| Dividend Yield | 0.02% | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 26.72 | Forward P/E | N/A |
| P/B Ratio | 2.71 | P/S Ratio | 4.04 |
| PEG Ratio | 1.06 | Forward PEG | N/A |
| EV/EBITDA | 20.94 | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | 4.52% | ||
| Market Cap | 44.53B | Enterprise Value | 51.81B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 11.03B | 11.23B | 11.30B | 10.86B | 9.55B |
| Net Income | 1.67B | 1.44B | 1.05B | 1.06B | 1.39B |
| EPS (Diluted) | 0.19 | 0.16 | 0.11 | 0.11 | 0.15 |
| Gross Profit | 7.14B | 6.82B | 6.96B | 6.58B | 5.95B |
| Operating Income | 2.47B | 2.21B | 2.00B | 1.83B | 1.64B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 32.62B | 34.32B | 34.06B | 34.82B | 34.45B |
| Total Liabilities | 16.14B | 18.09B | 17.33B | 18.36B | 7.97B |
| Shareholders' Equity | 16.42B | 16.17B | 16.61B | 16.33B | 26.36B |
| Total Debt | 8.61B | 10.10B | 9.46B | 10.44B | 991.00M |
| Cash & Equivalents | 1.32B | 2.20B | 1.04B | 684.00M | 414.00M |
| Current Assets | 4.55B | 5.72B | 4.82B | 4.06B | 5.25B |
| Current Liabilities | 4.93B | 5.81B | 4.64B | 4.37B | 4.24B |